Efg Asset Management (North America) Corp. Chemo Centryx, Inc. Transaction History

Efg Asset Management (North America) Corp.

  • $585 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
BUY
$15.36 - $27.51 $131,328 - $235,210
8,550 Added 15.98%
62,051 $1.54 Million
Q1 2022

Apr 26, 2022
SELL
$22.22 - $39.12 $10,621 - $18,699
-478 Reduced 0.89%
53,501 $1.34 Million
Q4 2021

Feb 18, 2022
BUY
$18.38 - $40.5 $992,134 - $2.19 Million
53,979 New
53,979 $1.97 Million

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email